Skye Bioscience, Inc. (SKYE)
SKYE Stock Price Chart
Explore Skye Bioscience, Inc. interactive price chart. Choose custom timeframes to analyze SKYE price movements and trends.
SKYE Company Profile
Discover essential business fundamentals and corporate details for Skye Bioscience, Inc. (SKYE) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
26 Nov 2014
Employees
16.00
Website
https://skyebioscience.comCEO
Punit S. Dhillon
Description
Skye Bioscience, Inc., a biopharmaceutical company, discovers, develops, and commercializes cannabinoid-based molecules for the treatment of infectious diseases. The company's lead product candidate is SBI-100, which is in Phase I trials for the treatment of glaucoma and ocular hypertension. It is also developing SBI-200 that is in preclinical trials to treat and manage various eye diseases, including uveitis, dry eye syndrome, macular degeneration and diabetic retinopathy. The company was formerly known as Emerald Bioscience, Inc. and changed its name to Skye Bioscience, Inc. in January 2021. Skye Bioscience, Inc. was founded in 2012 and is headquartered in San Diego, California.
SKYE Financial Timeline
Browse a chronological timeline of Skye Bioscience, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 6 May 2026
Upcoming earnings on 6 Nov 2025
EPS estimate is -$0.29.
Earnings released on 7 Aug 2025
EPS came in at -$0.44 falling short of the estimated -$0.34 by -29.41%.
Earnings released on 8 May 2025
EPS came in at -$0.28 surpassing the estimated -$0.31 by +9.68%.
Earnings released on 20 Mar 2025
EPS came in at -$0.24 surpassing the estimated -$0.28 by +14.29%.
Earnings released on 7 Nov 2024
EPS came in at -$0.22 surpassing the estimated -$0.26 by +15.38%.
Earnings released on 9 Aug 2024
EPS came in at -$0.20 matching the estimated -$0.20.
Earnings released on 10 May 2024
EPS came in at -$0.18 falling short of the estimated -$0.16 by -12.50%.
Earnings released on 22 Mar 2024
EPS came in at -$0.63 falling short of the estimated -$0.38 by -65.79%, while revenue for the quarter reached $163.39K .
Earnings released on 13 Nov 2023
EPS came in at -$3.17 .
Stock split effective on 8 Sept 2023
Shares were split 1 : 250 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 7 Aug 2023
EPS came in at -$0.80 .
Earnings released on 11 May 2023
EPS came in at -$2.50 .
Earnings released on 31 Mar 2023
EPS came in at -$5.00 .
Earnings released on 14 Nov 2022
EPS came in at -$2.50 .
Earnings released on 15 Aug 2022
EPS came in at -$2.50 .
Earnings released on 6 May 2022
EPS came in at -$2.50 .
Earnings released on 25 Mar 2022
EPS came in at -$1.52 .
Earnings released on 10 Nov 2021
EPS came in at -$1.10 .
Earnings released on 6 Aug 2021
EPS came in at -$2.50 .
Earnings released on 7 May 2021
EPS came in at -$2.50 .
Earnings released on 2 Mar 2021
EPS came in at -$1.32 .
Earnings released on 6 Nov 2020
EPS came in at -$1.26 .
SKYE Stock Performance
Access detailed SKYE performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.